Showing results (1321-1330 of 6,130) with videos related to

Sort By:
Pageof 613
International Journal of Antimicrobial Agents|September 28, 2025
Effectiveness and safety of tenofovir alafenamide fumarate-based therapy compared with tenofovir disoproxil fumarate- and abacavir-based therapy in children and young people living with HIV in Europe,
International Journal of Antimicrobial Agents|September 27, 2025
Machine learning in antimicrobial therapy for critically ill patients: optimizing early empirical regimens, individualized dosing, and de-escalation strategiesXinyun Huan, Linlin Hu, Hao Li, et al.
International Journal of Antimicrobial Agents|June 23, 2020
Pharmacodynamics of immune response biomarkers of interest for evaluation of treatment effects in bacterial infectionsAnders Thorsted, Elisabet I Nielsen, Lena E Friberg
International Journal of Antimicrobial Agents|September 15, 2021
Longitudinal Genomic Characterization of Carbapenemase-producing Enterobacteriaceae (CPE) Reveals Changing Pattern of CPE Isolated in Hong Kong HospitalsChendi Zhu, Carmen Li, Christopher K C Lai, et al.
International Journal of Antimicrobial Agents|September 15, 2021
The cathelicidin-derived close-to-nature peptide D-11 sensitises Klebsiella pneumoniae to a range of antibiotics in vitro, ex vivo and in vivoRubén Cebrián, Congjuan Xu, Yushan Xia, et al.
International Journal of Antimicrobial Agents|August 28, 2021
Hydroxychloroquine plus azithromycin early treatment of mild COVID-19 in an outpatient setting: a randomized, double-blinded, placebo-controlled clinical trial evaluating viral clearanceCristhieni Rodrigues, Rodrigo S Freitas-Santos, José Eduardo Levi, et al.
International Journal of Antimicrobial Agents|August 16, 2016
Short- versus long-duration levofloxacin plus rifampicin for acute staphylococcal prosthetic joint infection managed with implant retention: a randomised clinical trialJaime Lora-Tamayo, Gorane Euba, Javier Cobo, et al.
International Journal of Antimicrobial Agents|April 25, 2020
Does Escherichia coli have pathogenic potential at a low level of bacteriuria in recurrent, uncomplicated urinary tract infection?Yulia L Naboka, Ayrat R Mavzyiutov, Michel I Kogan, et al.
International Journal of Antimicrobial Agents|April 25, 2020
The tcdA-negative and tcdB-positive Clostridium difficile ST81 clone exhibits a high level of resistance to fluoroquinolones: a multi-centre study in Beijing, ChinaJing-Wei Cheng, Chang Liu, Timothy Kudinha, et al.
International Journal of Antimicrobial Agents|September 1, 2021
Cefazolin versus cloxacillin as definitive antibiotic therapy for methicillin-susceptible Staphylococcus aureus spinal epidural abscess: a retrospective cohort studyAnthony D Bai, Aidan Findlater, Neal Irfan, et al.
Pageof 613